ALZA Corporation

États‑Unis d’Amérique


 
Quantité totale PI 147
Quantité totale incluant filiales 147 (+ 0 pour les filiales)
Rang # Quantité totale PI 8 826
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 464 621
Parent Johnson & Johnson
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

27 3
1 11
99 0
6
 
Dernier brevet 2022 - Stable therapeutic formulations
Premier brevet 1971 - Drug delivery device
Dernière marque 2001 - DitropanXL
Première marque 1971 - ALZA

Filiales

1 subsidiaries with IP (0 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2021 Invention Stable therapeutic formulations. Compositions of and methods for formulating and delivering biol...
2020 Invention Transdermal administration of fentanyl and analogs thereof. A method and a non-rate controlled, ...
2018 Invention Once-a-day replacement transdermal administration of fentanyl. A method and a daily replacement ...
2017 Invention Electrotransport drug delivery devices and methods of operation. A switch-operated therapeutic a...
Invention Stable therapeutic formulations. Compositions of and methods for formulating and delivering biolo...
2016 Invention Transdermal nicotine salt delivery system. A transdermal nicotine salt delivery system to an ind...
Invention Electrotransport drug delivery device. A switch operated therapeutic agent delivery device is de...
2015 Invention Multilaminate backing construction. A novel backing construction for a transdermal drug delivery ...
Invention Microblade array impact applicator. An applicator device (10) is provided for applying a patch (4...
Invention Transparent transdermal nicotine delivery devices. A transparent transdermal delivery device for...
Invention High enhancer-loading polyacrylate formulation for transdermal applications. A polyacrylate form...
Invention Self-test for analgesic product. Electrotransport drug delivery devices, system and methods of us...
Invention Transdermal nicotine salt delivery system. A transdermal nicotine salt delivery system to an indi...
Invention Transparent transdermal nicotine delivery devices. A transparent transdermal delivery device for ...
2014 Invention Microprotrusion member retainer for impact applicator. A retainer (34) is provided for holding a ...
Invention Switch validation circuit and method. A switch-operated therapeutic agent delivery device is desc...
Invention High enhancer-loading polyacrylate formulation for transdermal applications. A polyacrylate formu...
Invention Multilayer drug delivery system with barrier against reservoir material flow. A multilayered dru...
2013 Invention Controlled release formulations of opioid and nonopioid analgesics. Sustained release dosage for...
Invention Methods and devices for providing prolonged drug therapy. Methods and devices for maintaining a d...
Invention Current control for electrotransport drug delivery. Devices, systems and methods for controlling ...
Invention Method of making a high enhancer-loading polyacrylate formulation for transdermal applications. A...
2012 Invention Iontophoretic drug delivery device
Invention Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dos...
Invention Method of storing an electrotransport drug delivery device. A switch operated therapeutic agent d...
Invention Two-part electrotransport device. A switch operated therapeutic agent delivery device is describe...
Invention Method for lowering blood glucose. The invention disclosed comprises a method for administering t...
2011 Invention Switch validation circuit and method. A switch operated therapeutic agent delivery device is desc...
2001 P/S Pharmaceutical preparations, namely a controlled release form of oxybutynin for treatment of urge...
P/S Pharmaceutical preparations for the treatment of disease and disorders of the central nervous sys...
2000 P/S Pharmaceutical preparations for the treatment of urological conditions. Pharmaceutical preparatio...
1999 P/S Pharmaceutical preparations.
P/S Pharmaceutical preparations, namely a controlled release form of oxybutynin for the treatment of ...
P/S Pharmaceuticals, namely oxybutynin.
P/S Pharmaceutical preparations for the treatment of disease and disorders of the central nervous system
1998 P/S Pharmaceutical and veterinary preparations and substances. Drug and other beneficial agent delive...
P/S Pharmaceutical and veterinary preparations and substances. Surgical, medical, dental and veterina...
P/S Pharmaceutical products in specialized dosage forms namely transdermal plasters, transdermal patc...
P/S Pharmaceutical preparations and substances; pharmaceutical preparations and substances for contro...
1997 P/S Pharmaceutical preparations, namely, a controlled release form of oxybutynin for the treatment of...
P/S Transdermal drug delivery systems. Product development services in the field of transdermal drug ...
P/S Transdermal drug delivery systems namely patches that permit the controlled administrations of dr...
1996 P/S Pharmaceutical and veterinary preparations and substances all for delivery by implantable drug de...
1992 P/S Liposome entrapped pharmaceutical preparations and diagnostic preparations.
1988 P/S Polymeric dispenser for slowly releasing drugs.
1981 P/S Polymeric Dispenser for Slowly Releasing Drugs
1978 P/S Urinary tract anti-spasmodic.
1971 P/S Drug delivery systems, namely, dosage forms and devices for administering drugs in a controlled m...